Phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for Elderly Patients with Adult T-Cell Leukemia/Lymphoma

Journal:

Blood

Published:

2025-05-16

DOI:

10.1182/blood.2024027902

Affiliations:

17

Authors:

20

Go to article

Institutions	Authors	Share
Imamura Hospital, Japan	2.000000	0.10
Nagoya City University, Japan	2.000000	0.10
Kagoshima University, Japan	2.000000	0.10
Kyushu Cancer Center, Japan	2.000000	0.10
University of Miyazaki, Japan	2.000000	0.10
Kumamoto University Hospital, Japan	1.000000	0.05
Nagoya University, Japan	1.000000	0.05
Wakayama Medical University, Japan	1.000000	0.05
Fukuoka University, Japan	1.000000	0.05
Aichi Cancer Center Hospital, Japan	1.000000	0.05
Kindai University, Japan	1.000000	0.05
Yamaguchi University, Japan	1.000000	0.05
National Hospital Organization Kagoshima Medical Center, Japan	1.000000	0.05
Kagoshima University Hospital, Kagoshima University, Japan	1.000000	0.05
Osaka General Hospital of West Japan Railway Company, Japan	1.000000	0.05

Interested in Oncology and Carcinogenesis?